Cancer Incidence and Mortality among Non-Hispanic Blacks, New York City, 2015-2019

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 9992.6 451.3 447.3-455.4 4758.4 530.0 523.0-537.0 5234.2 405.4 400.3-410.4 3222.8 147.5 145.2-149.8 1442.6 176.0 171.8-180.3 1780.2 132.6 129.8-135.5
Oral cavity and pharynx 172.4 7.8 7.3-8.3 104.0 11.6 10.6-12.7 68.4 5.2 4.7-5.8 44.6 2.0 1.8-2.3 29.6 3.4 2.9-4.0 15.0 1.2 0.9-1.5
Esophagus 73.2 3.2 2.9-3.6 45.6 5.2 4.5-5.9 27.6 2.1 1.7-2.5 47.0 2.1 1.8-2.4 29.8 3.5 3.0-4.2 17.2 1.2 1.0-1.5
Stomach 233.6 10.9 10.2-11.5 123.0 14.9 13.7-16.2 110.6 8.5 7.8-9.2 106.6 5.0 4.6-5.4 62.0 7.8 6.9-8.7 44.6 3.3 2.9-3.8
Colorectal 858.8 39.4 38.2-40.6 405.2 47.2 45.1-49.4 453.6 34.5 33.1-36.0 320.4 14.8 14.1-15.6 142.2 17.5 16.2-18.9 178.2 13.2 12.3-14.1
Colon excluding rectum 628.4 28.8 27.8-29.9 279.0 32.7 31.0-34.5 349.4 26.4 25.2-27.7 264.2 12.2 11.5-12.9 112.8 13.8 12.7-15.1 151.4 11.2 10.4-12.0
Rectum & rectosigmoid 230.4 10.6 10.0-11.2 126.2 14.5 13.3-15.7 104.2 8.1 7.4-8.9 56.2 2.6 2.3-2.9 29.4 3.6 3.1-4.3 26.8 2.0 1.7-2.4
Liver / intrahepatic bile duct 237.4 10.2 9.6-10.8 166.0 17.7 16.5-19.0 71.4 5.1 4.6-5.7 154.6 6.8 6.3-7.3 102.2 11.3 10.3-12.4 52.4 3.8 3.3-4.3
Pancreas 332.6 15.1 14.4-15.9 146.6 16.9 15.7-18.2 186.0 13.8 12.9-14.7 251.0 11.4 10.8-12.0 109.2 12.6 11.5-13.8 141.8 10.4 9.7-11.2
Larynx 70.0 3.0 2.7-3.4 52.2 5.9 5.2-6.7 17.8 1.3 1.0-1.6 24.8 1.1 0.9-1.3 17.8 2.1 1.7-2.6 7.0 0.5 0.3-0.7
Lung and bronchus 975.2 43.5 42.3-44.8 467.6 53.3 51.1-55.6 507.6 37.3 35.9-38.9 564.0 25.3 24.4-26.3 288.4 33.9 32.1-35.7 275.6 20.2 19.1-21.3
Melanoma of the skin 19.0 0.9 0.7-1.1 6.8 0.8 0.6-1.2 12.2 1.0 0.7-1.2 4.2 0.2 0.1-0.3 2.2 0.2 0.1-0.5 2.0 0.1 0.1-0.3
Female breast             1605.2 127.2 124.4-130.1             330.6 25.3 24.1-26.6
Cervix uteri             128.2 10.7 9.9-11.6             42.0 3.3 2.9-3.8
Corpus uterus and NOS             515.0 37.5 36.1-39.0             167.0 12.0 11.2-12.9
Ovary             126.8 9.9 9.1-10.7             91.2 6.7 6.1-7.4
Prostate       1929.4 203.6 199.4-207.8             253.0 34.5 32.6-36.5      
Testis       18.4 2.0 1.6-2.5             1.4 0.2 0.1-0.4      
Urinary bladder (incl. in situ) 223.4 10.3 9.7-10.9 149.0 18.4 17.1-19.8 74.4 5.5 5.0-6.1 59.4 2.8 2.5-3.1 34.4 4.5 3.9-5.3 25.0 1.8 1.5-2.2
Kidney and renal pelvis 337.4 15.1 14.3-15.8 205.8 22.7 21.3-24.2 131.6 9.9 9.1-10.7 52.8 2.4 2.1-2.7 34.2 4.1 3.4-4.7 18.6 1.3 1.1-1.6
Brain and other central nervous system 85.4 4.2 3.8-4.7 46.8 5.4 4.7-6.1 38.6 3.4 2.9-3.9 45.6 2.2 1.9-2.5 25.2 2.9 2.4-3.5 20.4 1.7 1.4-2.0
Thyroid 209.2 10.1 9.5-10.8 36.8 4.1 3.6-4.8 172.4 14.7 13.7-15.8 11.2 0.5 0.4-0.7 2.6 0.3 0.2-0.5 8.6 0.6 0.5-0.9
Hodgkin lymphoma 60.0 3.0 2.7-3.4 29.4 3.3 2.8-3.9 30.6 2.8 2.4-3.3 5.0 0.2 0.2-0.4 2.0 0.2 0.1-0.4 3.0 0.3 0.1-0.4
Non-Hodgkin lymphomas 344.6 16.2 15.5-17.0 167.4 19.3 17.9-20.7 177.2 14.2 13.3-15.2 85.6 4.0 3.7-4.4 42.4 5.1 4.4-5.9 43.2 3.3 2.9-3.8
Myeloma 319.4 14.6 13.8-15.3 143.4 16.6 15.4-17.9 176.0 13.3 12.4-14.2 104.8 4.8 4.4-5.2 49.2 6.0 5.3-6.8 55.6 4.1 3.6-4.6
Leukemias 223.2 10.7 10.1-11.4 106.8 12.7 11.6-13.9 116.4 9.4 8.7-10.3 99.2 4.7 4.3-5.1 49.6 6.0 5.2-6.8 49.6 3.9 3.4-4.4

Notes

  • Incidence data are provisional, November 2021.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.